Investigating the lysis of small-cell lung cancer cell lines by activated natural killer (NK) cells with a fluorometric assay for NK-cell- mediated cytotoxicity

Cancer Immunology Immunotherapy

Volumn 48, Issue 4, 1999, Pages 209-213

  Lehmann, C ^a   Glass, B ^a   Zeis, M ^a   Schmitz, N ^a   Uharek, L ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Cytotoxicity assay; Interleukin 12; NK cell; SCLC Interleukin 2

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERCELLULAR ADHESION MOLECULE 2; INTERCELLULAR ADHESION MOLECULE 3; INTERLEUKIN 12; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CELL ACTIVATION; CONTROLLED STUDY; CYTOLYSIS; EFFECTOR CELL; FLOW CYTOMETRY; FLUOROMETRY; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LUNG SMALL CELL CANCER; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PRIORITY JOURNAL; TARGET CELL;

CARCINOMA, SMALL CELL; CELL ADHESION MOLECULES; CYTOTOXICITY, IMMUNOLOGIC; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LUNG NEOPLASMS; LYMPHOCYTE ACTIVATION; TUMOR CELLS, CULTURED;

EID: 0032855441     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050567     Document Type: Article

References (19)

1. 1. Arase H, Arase N, Saito T (1995) Fas-mediated cytotoxicity by freshly isolated natural killer cells. J Exp Med 181:1235
2. 2. Badley RA, Martin WG, Schneider H (1973) Dynamic behaviour of fluorescent probes in lipid bilayer model membranes. Biochemistry 12:268
3. 3. Brunner KT, Mauel J, Cerottini JC, Chapuis B (1968) Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 14:181
4. 4. Chang L, Gusewitch GA, Chritton DB, Folz JC, Lebeck LK, Nehlsen-Cannarella SL (1993) Rapid flow cytometric assay for the assessment of natural killer cell activity. J Immunol Methods 166:45
5. 5. Henkart PA (1994) Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1:343
6. 6. Karre K, Ljunggren HG, Piontek G, Kiessling R (1986) Selective rejection of H-s-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319:675
7. 7. Lagadec PF, Saraya KA, Balkwill FR (1991) Human small-cell lung-cancer cells are cytokine-resistant but NK/LAK-sensitive. Int J Cancer 48:311
8. 8. Lanier LL, Corliss B, Phillips JH (1997) Arousal and inhibition of human NK cells. Immunol Rev 155:145
9. 9. Podack ER, Hengartner H, Lichtenheld MG (1991) A central role of perforin in cytolysis? Annu Rev Immunol 9:129
10. 10. Reiter Y, Ciobotariu A, Jones J, Morgan BP, Fishelson Z (1995) Complement membrane attack complex, perforin and bacterial exotoxins induce in K562 cells calcium dependent cross-protection from lysis. J Immunol 155:2203
11. 11. Shimizu Y, DeMars R (1989) Demonstration by class I gene transfer that reduced susceptibility of human cells to natural killer cell-mediated lysis is inversely correlated with HLA class I antigen expression. Eur J Immunol 19:447
12. 12. Soiffer RJ, Robertson MJ, Murray C, Cochran K, Ritz J (1993) Interleukin 12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies. Blood 82:2790
13. 13. Stam NJ, Kast WM, Voordouw AC, Pastoors LB, Hoeven FA van der, Melief CJ, Ploegh HL (1989) Lack of correlation between levels of MHC class I antigen and susceptibility to lysis of small cellular lung carcinoma (SCLC) by natural killer cells. J Immunol 142:4113
14. 14. Storkus WJ, Alexander J, Payne JA, Dawson JR, Cresswell P (1989) Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes. Proc Natl Acad Sci USA 86:2361
15. 15. Teichmann JV, Ludwig WD, Seibt Jung H, Thiel E (1989) Induction of lymphokine-activated killer cell against human leukaemia cells in vitro. Blut 59:21
16. 16. Uharek L, Zeis M, Glass B, Steinmann J, Dreger P, Gassmann W, Schmitz N, Muller-Ruchholtz W (1996) High lytic activity against human leukaemia cells after activation of allogeneic NK cells by IL-12 and IL-2. Leukemia 10:1758
17. 17. Vourka-Karussis U, Karussis D, Ackerstein A, Slavin S (1995) Enhancement of GVL effect with rhIL-2 following BMT in a murine model for acute myeloid leukaemia in SJL/J mice. Exp Hematol 23:196
18. 18. Young JDE, Leong LG, Liu CC, Damiano A, Cohn ZA (1986) Extracellular release of lymphocyte cytolytic pore-forming protein after ionophore stimulation. Proc Natl Acad Sci USA 83:5668
19. 19. Zarcone D, Tilden AB, Cloud G, Friedmann HM, Landay A, Grossi CE (1986) Flow cytometry evaluation of cell mediated cytotoxicity. J Immunol Methods 94:247